These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 310339)

  • 1. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
    Olkowski ZL; McLaren JR; Skeen MJ
    Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary results of combined surgery and adjuvant Bacillus Calmette-Guérin plus levamisole treatment of resectable lung cancer.
    Wright PW; Hill LD; Peterson AV; Pinkham R; Johnson L; Ivey T; Bernstein I; Bagley C; Anderson R
    Cancer Treat Rep; 1978 Nov; 62(11):1671-5. PubMed ID: 215304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of methotrexate and Bacillus Calmette-Guérin therapy for advanced head and neck cancer.
    Papac R; Minor DR; Rudnick S; Solomon LR; Capizzi RL
    Cancer Res; 1978 Oct; 38(10):3150-3. PubMed ID: 356962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular immunity in patients with epidermoid cancer of the head and neck.
    Papenhausen PR; Kukwa A; Croft CB; Borowiecki B; Silver C; Emeson EE
    Laryngoscope; 1979 Apr; 89(4):538-49. PubMed ID: 311881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
    Robinson E; Haim N; Segal R; Veseley Z; Mekori T
    Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levamisole in squamous cell carcinoma of the head and neck.
    Olivari AJ; Glait HM; Guardo A; Califano L; Pradier R
    Cancer Treat Rep; 1979 Jun; 63(6):983-90. PubMed ID: 380804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot clinical trial of the toxicity and immunorestorative effects of T cell reconstituting factor (SR 270258) in immunosuppressed cancer patients.
    Murray JL; Reuben JM; Smith TL; Gehan EA; Koretz SM; Hersh EM
    J Biol Response Mod; 1987 Feb; 6(1):56-68. PubMed ID: 2951501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical studies of methanol extraction residue fraction of Bacillus Calmette-Guérin as an immunostimulant in patients with advanced cancer.
    Moertel CG; Ritts RE; Schutt AJ; Hahn RG
    Cancer Res; 1975 Nov; 35(11 Pt 1):3075-83. PubMed ID: 1102082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunological outcome predictive score for head and neck carcinoma patients.
    Kaffenberger W; Hölzer-Müller L; Auberger T; Clasen BP; Hohlmeier G; van Beuningen D
    Strahlenther Onkol; 1995 Aug; 171(8):444-53. PubMed ID: 7652667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of levamisole immunotherapy as an adjuvant to radiotherapy in oral cancer. II. Lymphocyte subpopulations.
    Balaram P; Padmanabhan TK; Vasudevan DM
    Neoplasma; 1988; 35(2):235-42. PubMed ID: 3259681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of thymosin and irradiation on immune modulation in head and neck and esophageal cancer patients.
    Wara WM; Ammann AJ; Wara DW
    Cancer Treat Rep; 1978 Nov; 62(11):1775-8. PubMed ID: 728896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
    Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB
    Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Bacillus Calmette-Guérin and levamisole on immune responses in young adult and age-immunodepressed mice.
    Bruley-Rosset M; Florentin I; Kiger N; Davigny M; Mathé G
    Cancer Treat Rep; 1978 Nov; 62(11):1641-50. PubMed ID: 728893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transference of cell mediated immunity in patients with head and neck cancer.
    Vetto RM; Burger DR
    Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):79-82. PubMed ID: 304143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited squamous cell carcinoma of the lung: a Southwest Oncology Group randomized study of radiation with or without doxorubicin chemotherapy and with or without levamisole immunotherapy.
    White JE; Chen T; Reed R; Mira J; Stuckey WJ; Weatherall T; O'Bryan R; Samson MK; Seydel HG
    Cancer Treat Rep; 1982 May; 66(5):1113-20. PubMed ID: 7044532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
    Albers A; Abe K; Hunt J; Wang J; Lopez-Albaitero A; Schaefer C; Gooding W; Whiteside TL; Ferrone S; DeLeo A; Ferris RL
    Cancer Res; 2005 Dec; 65(23):11146-55. PubMed ID: 16322265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of levamisole in patients with squamous cancer of the head and neck: a preliminary report.
    Wanebo HJ; Hilal EY; Pinsky CM; Strong EW; Mike V; Hirshaut Y; Oettgen HF
    Cancer Treat Rep; 1978 Nov; 62(11):1663-9. PubMed ID: 365322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A murine model for the immunotherapy of head and neck squamous cell carcinoma.
    Hier MP; Black MJ; Shenouda G; Sadeghi N; Karp SE
    Laryngoscope; 1995 Oct; 105(10):1077-80. PubMed ID: 7564839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant vaccinia virus expressing interleukin-2 invokes anti-tumor cellular immunity in an orthotopic murine model of head and neck squamous cell carcinoma.
    Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK
    Mol Ther; 2006 Jan; 13(1):183-93. PubMed ID: 16125469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
    Yasumura S; Hirabayashi H; Schwartz DR; Toso JF; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1993 Mar; 53(6):1461-8. PubMed ID: 8443824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.